Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • 5 hours ago

Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in San Francisco.

Reuters • 2 hours ago

Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • 7 hours ago

Dividend Income: Lanny's November 2025 Summary

In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.

Seeking Alpha • 13 hours ago

CVS Health to hold fourth quarter and full year 2025 earnings conference call

WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.

PRNewsWire • Jan 9, 2026

Can These Dividend Stocks Beat the Market Again in 2026?

Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.

The Motley Fool • Jan 8, 2026

CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights

CVS Health (CVS) closed at $79.79 in the latest trading session, marking a -1.13% move from the prior day.

Zacks Investment Research • Jan 7, 2026

CVS Health declares quarterly dividend

WOONSOCKET, R.I., Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

PRNewsWire • Jan 6, 2026

Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are

A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) — are allegedly using shell companies to hide billions of dollars that Hunterbrook says should be used to lower drug prices for patients.

Benzinga • Jan 6, 2026

These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year.

With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.

Barrons • Jan 2, 2026